The World of Health & Medicine News

US court blocks most Trump tariffs, says president exceeded his authority

US court blocks most Trump tariffs, says president exceeded his authority

A U.S. trade court blocked President Donald Trump’s tariffs from going into effect in a sweeping ruling on Wednesday that found the president overstepped his authority by imposing across-the-board duties on imports from U.S. trading partners.

The Court of International Trade said the U.S. Constitution gives Congress exclusive authority to regulate commerce with other countries that is not overridden by the president’s emergency powers to safeguard the U.S. economy.

“The court does not pass upon the wisdom or likely effectiveness of the President’s use of tariffs as leverage,” a three-judge panel said in the decision to issue a permanent injunction on the blanket tariff orders issued by Trump since January. “That use is impermissible not because it is unwise or ineffective, but because [federal law] does not allow it.”

The judges also ordered the Trump administration to issue new orders reflecting the permanent injunction within 10 days. The Trump administration minutes later filed a notice of appeal and questioned the authority of the court.

The court invalidated with immediate effect all of Trump’s orders on tariffs since January that were rooted in the International Emergency Economic Powers Act (IEEPA), a law meant to address “unusual and extraordinary” threats during a national emergency.

The court was not asked to address some industry-specific tariffs Trump has issued on automobiles, steel and aluminum, using a different statute.

The decisions of the Manhattan-based Court of International Trade, which hears disputes involving international trade and customs laws, can be appealed to the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., and ultimately the U.S. Supreme Court.

spot_img

Explore more

spot_img

WHO chief still hopes Trump administration will rethink withdrawal

WHO chief still hopes Trump administration will rethink withdrawal The World Health Organization chief said on Thursday that he was still hoping the U.S. administration...

FDA approves first new antibiotics to treat gonorrhea in decades, with...

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance  The U.S. health regulator on Friday approved Innoviva's oral...

US FDA Approves First At-Home Device for Depression

US FDA Approves First At-Home Device for Depression The U.S. Food and ‌Drug ​Administration has approved Flow Neuroscience's ‌at-home brain stimulation device to treat depression,...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of...

FDA approves first gene therapy for rare immune disorder

FDA approves first gene therapy for rare immune disorder The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy...

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS Stopping GLP-1 weight-loss drugs before pregnancy appears to increase the risk of complications and preterm delivery, a new...

US FDA approves first drug under new fast-track review program

US FDA approves first drug under new fast-track review program The U.S. Food and Drug Administration approved on Tuesday the ​first drug under its new...

Global leaders commit $1.9 billion to eradicate polio amid funding cuts

Global leaders commit $1.9 billion to eradicate polio amid funding cuts Global leaders pledged $1.9 billion to advance polio eradication on Monday, accelerating efforts to...